Dr. Zhao has assembled the top experts in the field of urology to present state-of-the-art clinical reviews devoted to Male Urethral Reconstruction and the Management of Urethral Stricture Disease. The issue is divided into three sections, with focus on evlaluation and follow up, urethroplasty technique, and conditions affecting outcomes. Authors have specifically addressed the following topics: Definition of successful treatment and optimal follow up in urethral strictures; Cost analyses for evaluation and treatment of urethral strictures; Sexual dysfunction after urethroplasty; Endoscopic treatment of urethral stricture; Endoscopic treatment for urethral stenosis; Patient selection for urethroplasty technique: EPA vs Graft; Effect of graft location in urethroplasty; Non-transecting urethroplasty; Urethroplasty for panurethral urethral stricture; Use of alternative graft material in urethroplasty; Effect of Lichen Sclerosis on success of urethroplasty; Treatment of radiation induced urethral strictures; Effect of artificial urethral sphincters on strictures; Urethral strictures after transgender surgery; and Management of urethral strictures after hypospadias repair. Readers will come away with the current clinical diagnosis and management strategies that they can employ immediately.

This issue of Surgical Pathology Clinics focuses on diseases of the genitourinary tract: Prostate, Kidney, Bladder, Testes, and Adrenals. As with all information in this series, presentations relate to the daily practice of surgical pathologists. A practical and innovative feature in this issue is the inclusion of several articles from the "clinician's perspective" in which an oncologist discusses the diagnosis of the disease and relates this to the information they require from the pathologist. Topics include: Morphologic updates in prostate pathology; Molecular updates in prostate pathology; Diagnosis of prostate carcinoma: A clinician's perspective; Commonly encountered renal neoplasms; Emerging dntities in renal neoplasia; Diagnosis of renal cell carcinoma: A clinician's perspective; Morphologic and molecular characteristics of bladder cancer; Diagnosis of bladder carcinoma: A clinician's perspective; Overview of testicular neoplasia; Diagnosis of testicular cancer: A clinician's perspective; Overview of adrenal neoplasia; Diagnosis of adrenal carcinoma: A clinician's perspective; Benign lesions of the GU tract . Michelle Hirsch leads this issue with a group of expert genitourinary pathologists and oncologists.

This issue provides much needed updates since Dr. Sheinfeld's issue published in 2007. Dr. Lin has assembled expert authors to provide clinicians with the full breadth of clinical updates on testicular cancer. New to this issue are articles on clinical outcomes, survivorship, and several articles on the management of Nonseminomatous Germ Cell Tumors.

This issue of Hematology/Oncology Clinics of North America, guest edited by Dr. Joaquin Bellmunt, is devoted to Bladder Cancer. Articles in this issue include: Diagnosis and Staging of Bladder Cancer; Epidemiology of Bladder Cancer; Molecular Biology of Bladder Cancer; Pharmacogenomics in Bladder Cancer; Management of Non-muscle Invasive Bladder Cancer; Non-urothelial Bladder Cancer and Rare Variant Histologies; Management of UUT; New Trends in Surgical Management of Bladder Cancer; Bladder Preservation Strategies; Perioperative Therapy of Bladder Cancer (Neoadjuvant and Adjuvant); First Line Treatment and Prognostic Factors of Metastatic Disease: Platinum Eligible Patients; First Line Treatment of Metastatic Disease: Platinum Ineligible Patients; Salvage Therapy in Metastatic Disease; and Future Directions and Targeted Therapies in Bladder Cancer.

Eureka: General Surgery and Urology is an innovative book for medical students that fully integrates core science, clinical medicine and surgery. The book benefits from an engaging and authoritative text, written by specialists in the field, and has several key features to help you really understand the subject: Chapter starter questions - to get you thinking about the topic before you start reading Break out boxes which contain essential key knowledge Clinical cases to help you understand the material in a clinical context Unique graphic narratives which are especially useful for visual learners End of chapter answers to the starter questions A final self-assessment chapter of Single Best Answers to really help test and reinforce your knowledge The book starts with the First Principles chapter which clearly explains key concepts such as assessment of the patient fitness for surgery, patient consent and pain management. The Clinical Essentials chapter provides an overview of the symptoms and signs of surgical disease, investigations and management options. A series of disease-based chapters briefly describe, by system, relevant structure and function, history and examination and main surgical presentations, each chapter introduced by engaging clinical cases that feature unique graphic narratives. The Emergencies chapter covers the principles of immediate care in situations such as acute appendicitis. Finally, the Self-Assessment chapter comprises 80 multiple choice questions in clinical Single Best Answer format, to thoroughly test your understanding of the subject. The Eureka series of books are designed to be a 'one stop shop': they contain all the key information you need to know to succeed in your studies and pass your exams.

Each year nearly 35,000 men are diagnosed with prostate cancer. Of these, more than 10,000 die from the disease, and figures are rising. But better awareness, earlier diagnosis and more sophisticated treatments can save lives, and have already reduced death rates in some countries. This new edition of Coping Successfully with Prostate Cancer presents the latest research on prostate cancer and describes the many treatments available. Topics include; symptoms and stages of the disease, other prostate problems, the possible influence of diet, geography and viral factors, screening and investigation, including PSA, the decision to treat, or not to treat, treatments, including surgery and radiation therapy, branchytherapy and laser, dealing with advanced prostate cancer, lifestyle measures, coping with sex, research and the future. In this thoroughly updated and positive book, Dr Tom Smith says that it is possible for men with prostate cancer to lead successful, happy and fufilled lives.

This volume of the Urologic Clinics covers the indications, controversies, and complications of Lymphadenectomy in Urologic Oncology.? Cancer of the prostate, bladder, testicles, and kidney are covered, along with new imaging modalities and complications of open and minimally invasive lymphadenectomy.

Dr. Mydlo's issue provides a comprehensive review of the diagnosis, management, and treatment of penile and urethral cancer. Top experts in the field have supplied state-of-the-art clinical reviews devoted to core issues, such as Premalignant and early carcinomas of the penis and scrotum; Histopathology of malignant lesions of the penis and urethra; Penile cancer: clinical presentation, diagnosis and staging; Reconstruction of the penis after surgery; Micrographic surgery for penile tumors; Management of regional lymphatic drainage; Radiation therapy of cancer of the penis; and Cancer of male/female urethra.

Scientific Advances in Reconstructive Urology and Tissue Engineering is a comprehensive overview of reconstructive urology that spans male and female, pediatric, neuro-urology and trauma. Traditionally, this field has been focused solely on surgical principles with little attention to basic and translational research. However, recent advances in acellular matrices, scaffolds, stem cells and tissue engineering have changed this focus. This publication is the perfect bridge and definitive tome of the advances that will move the translational and basic science of reconstructive urology forward and allow readers to implement the findings in clinical practice. Through the use of both current case studies and future implications, the content bridges the gap from bench to bedside making it the perfect reference for translational benign urology researchers who wish to move the field of reconstructive surgery forward.

The Guest Editors of this issue of Urologic Clinics of North America have put together a comprehensive collection of articles that provides the current knowledge on urologic cancer immunotherapy. Expert authors have contributed clinical review articles on the following topics: Era of personalized vaccines for GU cancers; TCR and dendritic vaccine platforms for GU cancers; Neo-adjuvant platforms for GU cancer immunotherapy; Immune-editing in Cancer: Role of tumor microenvironment and immune-suppressive pathways in localized and aggressive disease; Clinical integration of neo-adjuvant platforms for prostate cancer immunotherapy; Immunotherapy for muscle and non-muscle invasive bladder cancer: BCG and beyond; Immunotherapy for metastatic bladder cancer; Immunotherapy options for metastatic castrate-resistant prostate cancer; Role of tissue infiltrating lymphocytes: Understanding TCR; Therapeutic platforms for IPSC-derived CAR-T; Immune-suppression in prostate cancer: Underlying causes and influence on response to immunotherapy; and Racial disparity in response to immunotherapy. Urologists will come away with the most current information they need to improve outcomes in the urologic cancer patient.

The guest editors, Dr. William Huang and Dr. Ezequiel Becher, have assembled a state-of-the art issue devoted to Advanced and Metastatic Renal Cell Carcinoma (RCC). They have secured expert authors to contribute clinical reviews on the important topics involving treating and managing patients with RCC. Specific articles are devoted to the following topics: Imaging for Metastatic RCC; Adjuvant Therapy for Localized High Risk RCC; Current Standards for Therapeutic Sequencing for Advanced RCC; Role of Lymphadenectomy in patients with advanced RCC; Cytoreductive Nephrectomy in the Era of TKI/IO - Who, When and Why; Minimally Invasive Surgery for Patients with Locally Advanced and Metastatic Disease RCC; Evolving Role of Urologists in the Management of Advanced RCC; Neoadjuvant Therapy for Locally Advanced RCC; Epidemiology and Risk Assessment/Biomarkers for Patients with Advanced RCC; Radiation Therapy for Patients with Metastatic RCC; Evolving Role of Metastatectomy for Patients with Metastatic RCC; and Management of Non-Clear Cell Metastatic RCC. Readers will come away with the information they need to treat and manage patients and to improve outcomes.

The 3rd edition of this popular text covers all aspects of continence, focusing on continence promotion and measurement of outcomes. The core chapters follow a standard structure for ease of use, and case studies are used throughout to link theory to practice. contains the latest developments in continence treatment incorporates the most recent NHS guidelines on continence management and current legislation includes international perspectives provides a resource for practitioners caring for all client groups in the community and hospital environments a website providing practical documentation along with downloadable charts and examples of continuing professional development activities a new chapter on vulnerable groups, including the frail elderly, and mental health and neurological problems points for continuing professional development at end of every chapter research evidence to guide practice

This book is partly based on research funded by Wereld Kanker Onderzoek Fonds based in the Netherlands and administered by the World Cancer Research Fund International grant program. Every year half a million of people worldwide are diagnosed with bladder cancer. With the recent zeitgeist of the self-empowered, intelligent patient who wishes to be well-informed, many cancer patients do not solely want to rely on decisions taken by medical practitioners, but actively participate in the journey from sickness to health or disease. While no books about the relationship between diet and bladder cancer currently exist, the poor quality of the existing information about the relationship between diet and health is shocking. Much of the information is exaggerated, not evidence-based, misleading and sometimes even incorrect. Dr. Maurice Zeegers, one of the world leading bladder cancer epidemiologists, and his co-authors set the record straight with this book on Diet and Fighting Bladder Cancer. Their aim is to provide purely evidence-based information about the relationship between diet and bladder cancer. The primary audience is bladder cancer patients who wish to be well-informed, although clinicians and healthcare workers may also find the book an interesting read. The book gives an honest reflection on what scientists know, but also what they don't yet know about how diet contributes to all stages of this important disease. Although science-based, the book is written in an easy-to-read format, illustrated with practical recipes.

Together with Consulting Editor Dr. Samir Taneja, Dr. Badrinath Konety has put together a comprehensive issue that addresses Salvage therapies for Non-Muscle Invasive Bladder Cancer. Expert authors have contributed clinical review articles on the following topics: BCG salvage therapy: Definition and context; Who will respond to BCG? Predictors and nomograms; Identification of candidates for salvage therapy: Definition of BCG "Failure"; Predictors of response to Intravesical therapy; Precision medicine for NMIBC; Salvage therapy using BCG derivatives or single agent chemotherapy; Intravesical heated Mitomycin: Biology and clinical utility; Mitomycin derivatives in the salvage setting; Combination intravesical therapy; Intravesical gene therapy; Immunoncology as salvage therapy; Role of IDO inhibitors in salvage therapy; and Novel agents for intravesical therapy. Readers will come away with the clinical information they need to improve outcomes in patients with bladder cancer.

In consultation with Consulting Editor, Dr. Samir Taneja, Dr. Sia Daneshmand has put together a state-of the-art issue of the Urologic Clinics devoted to Modern Management of Testicular Cancer. The issue focuses on surgical techniques and diagnostic modalities for testicular cancer. Clinical review articles are specifically devoted to the following: Imaging For Testicular Cancer; Management of Stage I Germ Cell Tumors; Management of Stage II Germ Cell Tumors; Current Management Of Disseminated GCT; Post-Chemotherapy Resection of Residual Mass in NSGCT; Indications For Surgery in Disseminated Seminoma; Growing Teratoma Syndrome; Management of The Primary Testicular Tumor; High-Dose Chemotherapy and Autologous Stem Cell Transplantation; mRna As Biomarkers For Germ Cell Tumors; Minimally Invasive RPLND: Is There a Role?; Complications of RPLND; Preservation of Fertility in Testis Cancer Management. Readers will come away with the latest information they need to optimize surgical and management outcomes in the patient with testicular cancer.